The state of the hunt:Moderna’s mRNA-based vaccine secured Emergency Use Listing from WHO.
Merck entered voluntary licensing agreements with five Indian drugmakers for its investigational antiviral molnupiravir.
Biological E’s subunit vaccine candidate advanced to Phase 3.
Approved or authorized vaccines
WHO granted Moderna’s vaccine Emergency Use Listing on Friday, according to a press release from the…